Anaphylactic reactions are rare emergencies observed in patients with inherited bleeding disorders. When these adverse events occur in patients with inhibitors, they further complicate the management of an already challenging clinical situation. Anaphylactoid inhibitors have been reported in patients with inhibitors associated with hemophilia A, hemophilia B, and type 3 von Willebrand disease. In this review, we summarize the current literature data on the occurrence of anaphylactoid reactions in patients with inherited bleeding disorders and alloantibodies. In particular, we focus on the pathophysiology of the inhibitor development and its management Blood Coagul Fibrinolysis 20:225-229. © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Anaphylaxis in patients with congenital bleeding disorders and inhibitors. [Review]
Lippi G.;Montagnana M.;Targher G.;Zaffanello M.;Salvagno G. L.;Tagliaferri A.
2009-01-01
Abstract
Anaphylactic reactions are rare emergencies observed in patients with inherited bleeding disorders. When these adverse events occur in patients with inhibitors, they further complicate the management of an already challenging clinical situation. Anaphylactoid inhibitors have been reported in patients with inhibitors associated with hemophilia A, hemophilia B, and type 3 von Willebrand disease. In this review, we summarize the current literature data on the occurrence of anaphylactoid reactions in patients with inherited bleeding disorders and alloantibodies. In particular, we focus on the pathophysiology of the inhibitor development and its management Blood Coagul Fibrinolysis 20:225-229. © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
